Federal Health Grants

This funding opportunity supports collaborative research efforts to improve the prevention, treatment, and understanding of cancers associated with HIV, involving various specialized teams and clinical trials accessible to diverse populations.

This funding opportunity provides financial support to U.S. state governments to improve healthcare access and quality in rural communities through innovative programs and workforce development initiatives.

This funding opportunity supports late-stage graduate students from diverse backgrounds in biomedical research, helping them transition to postdoctoral positions while promoting broader participation in the research workforce.

This funding opportunity supports researchers analyzing existing genomic data related to dental, oral, and craniofacial health to address research gaps and improve health outcomes.

This funding opportunity supports early postdoctoral fellows from diverse backgrounds in cancer research, providing them with mentorship and training to advance their careers in addressing health disparities and enhancing the cancer research workforce.

This Notice of Funding Opportunity (NOFO) announces the opportunity to apply for New Access Points (NAP) funding under the Health Center Program. The purpose of this funding is to support new health center service delivery sites to expand affordable, accessible, and high-quality primary health care for underserved communities and populations. In this NOFO, such sites are referred to as new access points. Award recipients will use NAP funding to provide primary health care services at one or more new access points.

The "NIA Renewal and Competing Revision Cooperative Agreements in Aging Research" grant is a funding opportunity for the renewal and revision of existing U01 research projects related to aging, including areas such as genetics, biology, neuroscience, clinical studies, and Alzheimer's disease, with the requirement that applicants integrate their systems with the Clinical Research Operations Management System (CROMS) for data management.

This is a Notice of Funding Opportunity (NOFO) full package to solicit applications for one cooperative agreement from qualified entities to implement the Integrated Health Systems Strengthening (IHSS). Eligibility for this award is not restricted. The purpose of the Integrated Health System Strengthening (IHSS) program is to accelerate countries Health System Strengthening (HSS) efforts and achieve sustainable, equitable, and resilient health systems through locally-led, evidence-driven, and context-specific approaches to HSS. The primary goals are to advance primary health care (PHC), accelerate progress toward universal health coverage (UHC), and improve health outcomes. Investments in HSS help USAID reach its priority global health goals of preventing child and maternal deaths, controlling the HIV/AIDS epidemic, and combating infectious disease, which directly contributes to strengthening global health security. A strengthened and accessible health system is necessary to yield high-quality health services, which are essential for achieving sustainable improvements in health, promoting economic growth, and overall democratic development.Please find the entire full announcement in the "Related Documents" tab.Issue Date: May 07, 2024Q Due Date: May 21, 2024Closing Date: July 06, 2024Closing Time: 11:59 PM EST (Washington, DC)Amendment 1 with questions/answers has been added: May 31, 2024

This funding opportunity provides financial support to public and nonprofit organizations that deliver essential primary health care services to underserved communities across the U.S., ensuring access regardless of patients' ability to pay.

HRSA-25-002, HRSA-25-003, and HRSA-25-004 announces the opportunity to apply for funding under Ryan White HIV/AIDS Program (RWHAP) Part C Early Intervention Services (EIS) Program: Existing Geographic Service Areas. The purpose of this program is to provide comprehensive primary health care and support services in an outpatient setting for low-income people with HIV. Under this announcement, successful applicants must provide: (1) counseling for individuals with respect to HIV; (2) targeted HIV testing; (3) periodic medical evaluations of individuals with HIV and clinical and diagnostic services for HIV care and treatment; (4) therapeutic measures for preventing and treating the deterioration of the immune system, and for preventing and treating conditions arising from HIV; and (5) referrals for people with HIV to appropriate providers of health care and support services. These services are to be provided directly or through referrals, contracts, or memoranda of understanding (MOUs). This competition is open to current RWHAP Part C EIS recipients and new organizations proposing to provide RWHAP Part C EIS funded services in the geographic service areas listed in Appendix C. Please note that there are 3 funding announcement numbers included in this document with 3 different periods of performance (See Appendix C). If you are applying for more than one service area, you must submit a separate application for each proposed service area. All allowable services must relate to HIV diagnosis, care, and support, and must adhere to established HIV clinical practice standards consistent with U.S. Department of Health and Human Services (HHS) Guidelines. Please refer to the HIV/AIDS Bureau (HAB) Policy Clarification Notice (PCN) 16-02 Ryan White HIV/AIDS Program Services for a list of RWHAP allowable core medical and support services and their descriptions. According to the RWHAP Part C statute: At least 50 percent of the amount received under the award must be expended on EIS costs (except counseling and referrals/linkage to care); At least 75 percent of the award (after reserving amounts for administrative costs, planning/evaluation, and clinical quality management (CQM)) must be expended on core medical services costs (Please note: EIS is a subset of this 75 percent of the award) and; Not more than 10 percent of the total RWHAP Part C award funds can be expended on administrative costs. Applicants seeking a waiver to the core medical services requirement must submit a waiver request with this application as Attachment 15. For more details, see Program Requirements and Expectations.

Research shows that HIV care must increasingly address the management of individuals with multiple coexisting diseases (p.357) such as infectious and chronic diseases, mental health and behavioral disorders, food insecurity, substance use, etc. Since individual diseases do not exist in a vacuum, neither does the management, or burden of disease on community well-being. In response, syndemic theory and approaches are used to (1) increase the focus on co-occurring and interacting disease and social conditions that exacerbate health inequities, and (2) advance the evidence base for effective approaches to assess, monitor, and intervene with respect to these co-occurring and interacting factors for optimal outcomes in HIV treatment and care. The purpose of this project is to design, implement, and evaluate innovative comprehensive interventions part of an integrated treatment plan , using a syndemic approach to address co-occurring and interacting conditions of HIV, substance use disorder, intimate partner violence (IPV), and other social determinants of health that impact health outcomes of racial and ethnic minorities with HIV.

The purpose of the NCCC program is to provide rapid, expert, and culturally competent clinical consultation and advice to health care team members on a wide range of HIV and HIV-related topics. The NCCC, using a combination of various funding sources, provides services through telephone-based warmlines, a hotline, and internet-based educational consultation services in the following clinical areas: General HIV prevention, care, and treatment, including diagnosis, testing, and antiretroviral therapy. Pre-exposure prophylaxis (PrEP). Post-exposure prophylaxis (PEP). Treatment and management of Hepatitis B and C and HIV coinfections. Treatment and management of substance use disorders in people with or at risk for HIV. Perinatal HIV care and management. The NCCC provides expert consultation that demonstrates an understanding of the HIV epidemic in a variety of locations including: EHE jurisdictions. Rural areas. Areas disproportionately impacted by substance use disorders including opioid use disorder, and other co-morbidities. Communities where a large number of the people with HIV identify as a non-white racial or ethnic group. The goals for the NCCC align with those of the RWHAP Part F AETC Program, which are: Goal 1: Expand the number of health care team members providing HIV care and prevention services, including providers with different backgrounds or experiences. Goal 2: Expand the ability of health care team members to provide effective HIV care and prevention services. Goal 3: Improve health equity by integrating HIV care and prevention in primary care and other health care settings that provide services to underserved populations. Goal 4: Enhance the capacity of the AETC Program to train health care team members to serve people at risk for or with HIV.

This grant provides funding to organizations that help victims of domestic violence and their pets by offering shelter, housing assistance, and related services.

This funding opportunity is designed to support clinical centers conducting research on the development of Type 1 diabetes following episodes of acute pancreatitis, focusing on understanding its causes, progression, and risk factors in a diverse population.

The purpose of the Medical Student Education (MSE) Program is to provide support to public medical schools in the top quintile of states with a projected primary care physician shortage to expand or support education for medical students preparing to become physicians. The program is designed to prepare and encourage medical students in these schools to choose residencies and careers in primary care and serve tribal, rural, and/or medically underserved communities in those states after they complete their residency.

This funding opportunity supports researchers in low- and middle-income countries to conduct important studies on infectious diseases that address local health challenges and build scientific capacity.

This funding opportunity supports small businesses that have completed a Phase II SBIR or STTR award in advancing clinical trials and research projects for medical products, particularly those requiring federal regulatory approval, while encouraging partnerships with investors to ensure commercial viability.

This funding opportunity provides financial support to organizations that will help improve diabetes prevention and management for underserved populations by offering expertise, training, and resources to enhance health equity.

This funding opportunity provides financial support to law enforcement agencies across the U.S. to improve the mental health and wellness services available to their officers.

The Catalyze Product Definition Funding Opportunity Announcement (FOA) offers early-stage financial support for the discovery and study of potential treatments for heart, lung, blood, and sleep diseases, with the goal of progressing these projects to a stage where they qualify for the NHLBI Catalyze Preclinical program or secure funding from other sources for further development.